Y-Intercept (HK)’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$500K Sell
2024
Q3
$1.02M Buy
2024
Q2
$575K Buy
2024
Q1
Sell
2023
Q4
$678K Buy